Guía de Práctica Clínica sobre Lupus Eritematoso Sistémico

807 Tarr T, Gyorfy B, Szekanecz E, Bhattoa HP, Zeher M, Szegedi G et al. Occurrence of
Malignancies in Hungarian Patients with Systemic Lupus Erythematosus: Results from a
Single Center. Ann N Y Acad Sci 2007; 1108: 76–82.
808 Bernatsky SR, Cooper GS, Mill C, Ramsey-goldman R, Clarke ANNE, Pineau CA.
Cancer Screening in Patients with Systemic Lupus Erythematosus. J Rheumatol 2006; 33:
45–49.
809 Yazdany J, Tonner C, Trupin L, Panopalis P, Gillis JZ, Hersh AO et al. Provision of
preventive health care in systemic lupus erythematosus: data from a large observational
cohort study. Arthritis Res Ther 2010; 12: R84.
810 Kipenm Y, Littlejohn G, Morand E. Methotrexate use in systemic lupus erythematosus.
Lupus 1997; 6: 385–389.
811 Sen D, Keen R. Osteoporosis in systemic lupus erythematosus : prevention and treatment.
Lupus 2001; 1: 227–232.
812 Alele JD, Kamen DL, Hunt KJ, Ramsey-Goldman R. Bone geometry profiles in women
with and without SLE. J Bone Miner Res 2011; 26: 2719–2726.
813 Boyanov M, Robeva R, Popivanov P. Bone mineral density changes in women with
systemic lupus erythematosus. Clin Rheumatol 2003; 22: 318–323.
814 Houssiau FA, Lefebvre C, Depresseux G, Lambert M, Devogelaer J. Trabecular and
cortical bone loss in systemic lupus erythematosus. Br J Rheumatol 1996; 35: 244–247.
815 Jacobs J, Korswagen L, Schilder a M, van Tuyl LH, Dijkmans B a C, Lems WF et al. Sixyear
follow-up study of bone mineral density in patients with systemic lupus
erythematosus. Osteoporos Int 2013; 24: 1827–1833.
816 Korczowska I, Olewicz-gawlik A, Hrycaj P, Lacki J. The Effect of Long-term
Glucocorticoids on Bone Metabolism in Systemic Lupus Erythematosus Patients: The
Prevalence of Its Anti-inflammatory Action upon Bone Resorption. Yale J Biol Med 2003;
76: 45–54.
817 Tang XL, Griffith JF, Qin L, Hung VW, Kwok a W, Zhu TY et al. SLE disease per se
contributes to deterioration in bone mineral density, microstructure and bone strength.
Lupus 2013; 22: 1162–1168.
818 Tang XL, Zhu TY, Hung VW, Qin L, Wong C-K, Kun EW et al. Increased organ damage
associated with deterioration in volumetric bone density and bone microarchitecture in
patients with systemic lupus erythematosus on longterm glucocorticoid therapy. J
Rheumatol 2012; 39: 1955–1963.
819 Mak A, Lim JQ, Liu Y, Cheak AA, Ho RC. Significantly higher estimated 10-year
probability of fracture in lupus patients with bone mineral density comparable to that of
healthy individuals. Rheumatol Int 2013; 33: 299–307.
820 Lee JJY, Aghdassi E, Cheung AM, Morrison S, Cymet A, Peeva V et al. Ten-year
absolute fracture risk and hip bone strength in Canadian women with systemic lupus
erythematosus. J Rheumatol 2012; 39: 1378–1384.
496 GUÍAS DE PRÁCTICA CLÍNICA EN EL SNS